Although we did not test whether increasing MetMab to higher concentrations may saturate MET binding, preventing its dimerization and signaling,  resulting in inhibition of METamp cell proliferation and tumor growth, our results do  suggest the use of neutralizing antibodies to inhibit HGF-dependent tumor growth. The gene discussed is HGF; the disease is neoplasm.